Semaglutide
Description
Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism.
Documents
Local GMP +DMF + FDA EIR
- CAS: 910463-68-2
- MF: C187H291N45O59
- MW: 4113.57754
- Purity: 98%
- Solubility: Soluble in water
- Appearance: White or almost white powder
- Storage Temp: -15°C to -25°C
- Indication: Type II diabetes